CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (1,572,000)	$ (973,000)
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of operating lease right-of-use asset	39,000	35,000
Loss from investments in unconsolidated entities	116,000	470,000
Distributed earnings from unconsolidated entities	11,000	0
Accrued interest from notes receivable	0	0
Impairment of Goodwill	315,000	0
Deferred income taxes	0	0
Changes in:
Accounts receivable	0	346,000
Income taxes receivable/payable	(243,000)	303,000
Other current assets	47,000	34,000
Accounts payable and accrued expenses	(83,000)	(1,000)
Deferred revenue	0	0
Operating lease right-of-use liability	(43,000)	(40,000)
Net cash used in operating activities	(1,413,000)	174,000
Cash flows from investing activities:
Advances to unconsolidated entities	(744,000)	(491,000)
Repayments from loans to unconsolidated entities	274,000	22,000
Capital contributions to unconsolidated entities	(2,000)	0
Loss from investments in unconsolidated entities, net	1,244,000	0
Principal payments received under sales-type sublease	0	532,000
Net cash provided by investing activities	772,000	63,000
Cash flows from financing activities:
Repayment of finance lease obligations	0	(89,000)
Net cash used in financing activities	0	(89,000)
Net change in cash and cash equivalents	(641,000)	148,000
Cash and cash equivalents - beginning of year	2,178,000	2,030,000
Cash and cash equivalents - end of year	1,537,000	2,178,000
Cash paid for:
Interest	0	3,000
Income taxes	211,000	213,000
Supplemental disclosure of noncash investing and financing activities:
Issuance of subsidiary shares in exchange for a controlling interest in Elite Health Plan, Inc.	$ 0	$ 315,000